A novel chemokine-receptor-5 (CCR5) blocker, SCH532706, has differential effects on CCR5+CD4+ and CCR5+CD8+ T cell numbers in chronic HIV infection. [electronic resource]
Producer: 20100920Description: 653-61 p. digitalISSN:- 1931-8405
- Adult
- Anti-HIV Agents -- administration & dosage
- CCR5 Receptor Antagonists
- CD4-Positive T-Lymphocytes -- drug effects
- CD8-Positive T-Lymphocytes -- drug effects
- Cytomegalovirus -- immunology
- Dendritic Cells -- drug effects
- HIV Infections -- drug therapy
- Herpesvirus 1, Human -- immunology
- Humans
- Leukocyte Count
- Male
- Middle Aged
- Mycobacterium tuberculosis -- immunology
- T-Lymphocyte Subsets -- drug effects
- Viral Load
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.